$1.41
-0.14-9.03%
Últ. Act.: Nov 6, 9:30 AM
Alzamend Neuro (ALZN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | Sep 10, 2026 | $-0.68 | $-0.56 | -21.4 % |
| Q4 | Jul 22, 2026 | $-0.74 | $-0.67 | -10.4 % |
| Q3 | Mar 11, 2026 | $-0.58 | $-1.45 | 60.0 % |
| Q2 | Dec 9, 2025 | $-0.30 | $-1.51 | 80.1 % |
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.67 | $-1.45 | $-1.51 |
| Actual | $-0.68 | $-0.74 | $-0.58 | $-0.30 |
| Surprise | -21.4% | -10.4% | +60.0% | +80.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.22 | $-0.22 | $-0.22 |
| Revenue | ||||
| Consensus | — | — | — | — |